Showing results (301-310 of 330) with videos related to
Sort By:
Pageof 33
Journal of the National Cancer Institute|December 27, 2007
Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology StudyLisbeth Bertelsen, Leslie Bernstein, Jørgen H Olsen, et al.Cancer Epidemiology|May 29, 2012
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancerEva Lundin, Isaac Wirgin, Annekatrin Lukanova, et al.Human Mutation|September 8, 2011
Variants in activators and downstream targets of ATM, radiation exposure, and contralateral breast cancer risk in the WECARE studyJennifer D Brooks, Sharon N Teraoka, Anne S Reiner, et al.Journal of the National Cancer Institute|May 19, 2017
Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE StudyMark E Robson, Anne S Reiner, Jennifer D Brooks, et al.Radiation Research|August 17, 2023
Trends in Radiation Dose to the Contralateral Breast During Breast Cancer Radiation TherapyGordon P Watt, Susan A Smith, Rebecca M Howell, et al.Cells|December 24, 2021
A Functional Precision Medicine Pipeline Combines Comparative Transcriptomics and Tumor Organoid Modeling to Identify Bespoke Treatment Strategies for GlioblastomaMegan R Reed, A Geoffrey Lyle, Annick De Loose, et al.Scientific Data|July 2, 2025
Consistently processed RNA sequencing data from 50 sources enriched for pediatric dataHolly C Beale, Katrina Learned, Ellen T Kephart, et al.Health Physics|March 27, 2015
A report from the 2013 international symposium: the evaluation of the effects of low-dose radiation exposure in the life span study of atomic bomb survivors and other similar studiesE J Grant, K Ozasa, N Ban, et al.Radiation Research|November 26, 2008
Prevalence of adult-onset multifactorial disease among offspring of atomic bomb survivorsS Fujiwara, A Suyama, J B Cologne, et al.Human Genetics|May 6, 2026
A novel splice site variant in DEGS1 leads to aberrant splicing and loss of DEGS1 enzyme activity, a VUS resolvedHolly C Beale, Victor Tse, Joanna Y Lee, et al.Pageof 33